toripalimab   Click here for help

GtoPdb Ligand ID: 12989

Synonyms: JS-001 | JS001 | Loqtorzi® | toripalimab-tpzi
Approved drug Immunopharmacology Ligand
toripalimab is an approved drug (FDA (2023))
Compound class: Antibody
Comment: Toripalimab (JS001) is an anti-programmed cell death protein-1 (PD-1) immuno-oncology biologic [3]. It blocks the inhibitory immune checkpoint interaction between PD-1 and its ligands and reinstates a cytotoxic T cell response against tumour cells.
Click here for help
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2023))
International Nonproprietary Names Click here for help
INN number INN
10820 toripalimab
Synonyms Click here for help
JS-001 | JS001 | Loqtorzi® | toripalimab-tpzi
Database Links Click here for help
GtoPdb PubChem SID 485206110
Search PubMed clinical trials toripalimab
Search PubMed titles toripalimab
Search PubMed titles/abstracts toripalimab